Ischaemic preconditioning of the liver: A preliminary study

Australian and New Zealand Journal of Surgery

Volumn 66, Issue 10, 1996, Pages 707-710

  Hardy, Kenneth J ^a,b   McClure, David N ^a   Subwongcharoen, Somboon ^a  

^a AUSTIN HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Liver; Preconditioning; Resection

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; LIVER ISCHEMIA; LIVER RESECTION; LIVER SURGERY; MALE; NONHUMAN; PRECONDITIONING; RAT; REPERFUSION INJURY; SURGICAL TECHNIQUE;

EID: 0029830016     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.1996.tb00722.x     Document Type: Article

References (33)

1. Foster JH, Berman MM. Solid liver tumours. Major Prob. Clin. Surg. 1977; 21: 1-342.
2. Huguet C, Nordlinger B, Bloch P, Conrad J. Tolerance of the human liver to prolonged normothermic ischaemia. Arch. Surg. 1978; 113: 1448-51.
3. Nordlinger B, Douvin D, Javandin L et al. An experimental study of survival after 2 hours of normothermic hepatic ischaemia. Surg. Gynecol. Obstet. 1980; 150: 859-864.
4. Pachter HL, Spencer FC, Hofstetter SR, Coppa G. Experience with finger fracture technique to achieve intra hepatic haemostasis in 75 patients with severe injuries of the liver. Ann. Surg. 1983; 197: 771-8.
5. Delva E, Barberousse J, Nordlinger B et al. Haemo-dynamic and biochemical monitoring during major liver resection with use of hepatic vascular exclusion. Surgery 1984; 95: 309-18.
6. Bismuth H, Castaing D, Garden OJ. Major hepatic resection under total vascular exclusion. Ann. Surg. 1989; 210: 13-19.
7. Kawano K, Kim YI, Kaketani K, Kobayashi M. The beneficial effect of cyclosporin on liver ischaemia in rats. Transplantation 1989; 48: 759-64.
8. Hardy KJ, Tancharoen S, Shulkes A. Comparison of continuous versus intermittent ischaemia-reperfusion during liver resection in an experimental model. Br. J. Surg. 1995; 82: 833-6.
9. Marber M, Walker D, Yellon D. Ischaemic preconditioning: New insights into myocardial protection. BMJ 1994; 308: 1-2.
10. Isozaki H, Adam R, Gigou M, Szekely AM, Shen M, Bismuth H. Experimental study of the protective effect of intermittent hepatic pedicle clamping in the rat. B. J. Surg. 1992; 79: 310-13.
11. Murry CE, Jennings RB, Reimar KA. Preconditioning with ischaemia: A delay of lethal cell injury in ischaemic myocardium. Circulation 1986; 74: 1124-36.
12. Liu GS, Thornton J, Van Winkle DM, Stanley AWH, Olsson RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptor in rabbit heart. Circulation 1991; 84: 350-6.
13. Kloner RA, Yellon D. Does ischaemic preconditioning occur in patients? J. Am. Coll. Cardiol. 1994; 24: 1133-42.
14. Murry CE, Jennings RB, Reimar KA. What is ischaemic preconditioning? In: Przyklenk K (ed.). Preconditioning: The Concept of Endogenous Protection. Norwell, MA: Kluwer Academic, 1994; 3-17.
15. Downey JM, Liu Y, Ytrehus K. Adenosine and the anti-infarct effects of preconditioning. In: Przyklenk K (ed.). Preconditioning: The Concept of Endogenous Protection. Norwell, MA: Kluwer Academic, 1994; 137-52.
16. Walker DM, Walker JM, Marber M, Yellon DM. Protection by preconditioning is independent of arterial perfusion (Abstract). J. Am. Coll. Cardiol. 1994; 1A: 735.
17. Richard V, Kaeffer N, Tron C, Thuillez C. Impaired endothelium-dependent relaxations of rat coronary arteries after ischaemia and reperfusion: Prevention by preconditioning (Abstract). J. Am. Coll. Cardiol. 1994; 1A: 726.
18. Weimer G, Schölkens BA, Becker HA, Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 1991; 18: 558-63.
19. Shirotani P, Yui Y, Hattoi R, Kawai C. U61, 431F, a stable prostaglandin analogue, inhibits the proliferation of bovine vascular smooth muscle cells with little antiproliferative effect on endothelial cells. Prostaglandins 1991; 41: 97-110.
20. Greig PO, Woolf GM, Abecarsin M, Foster J, Strassberg BR. Prostaglandin E1 for primary nonfunction following liver transplantation. Transplant. Proc. 1989; 21: 3360-1.
21. Abe T, Lynch S, Balderstone G et al. The effects of prostaglandin analogue OP-41483 on normothermic liver ischaemia and reperfusion injury in rats. Prostaglandins Leukot. Essent. Fatty Acids 1993; 49: 417-22.
22. Ruwart MJ, Rush RD, Friedle NM, Piper RE, Kolaja GJ. Protective effects of 16, 16-dimethyf PGE2 on rat liver and kidney. Prostaglandins 1981; 21 (Suppl. 1): 97-102.
23. Hardy KJ, Tancharoen S, Shulkes A. Hepatic ischaemia-reperfusion injury modification during liver surgery in rats: Pretreatment with nifedipine or misoprostol. Liver Transplant. Surg. 1995; 1: 1-10.
24. Grace PA. Ischaemia-reperfusion injury. Br. J. Surg. 1994; 81: 637-47.
25. Parks DA, Granger DN. Ischaemia reperfusion injury, a radical view. Hepatology 1988; 8: 680-3.
26. Pretto EA. Reperfusion injury of the liver. Transplant. Proc. 1991; 23: 1912-14.
27. Thurman DG, Apel E, Baar M, LeMasters JJ. Protection of liver by calcium entry blockers. Ann. NY Acad. Sci. 1988; 522: 757-70.
28. Toledo-Pereyra LH, Suzuki S. Neutrophils, cytokins and adhesion molecules in hepatic ischaemia and reperfusion injury. J. Am. Coll. Surg. 1994; 179: 758-62.
29. McCord JM. Oxygen derived free radicals in post ischaemic tissue injury. N. Engl. J. Med. 1983; 312: 157-63.
30. Naylor WG, Panagiotopoulos S, Elz J, Daly MJ. Calcium-mediated damage during post-ischaemic reperfusion. J. Mol. Cell. Cardiol. 1989; 20 (Suppl. 2): 41-54.
31. Attala SL, Toledo-Pereyra LH, McKenzie GH, Cederna JP. Influence of oxygen-derived free radical scavengers on ischaemic livers. Transplantation 1985; 40: 584-90.
32. Mathews WK, Guido DM, Fisher MA, Jaeschke H. Lipid peroxidation as molecular mechanism of liver cell injury during reperfusion after ischaemia. Free Radic. Biol. Med. 1994; 16: 763-70.
33. Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver in vivo. Am. J. Physiol. 1991; 260: G355-62.